Press "Enter" to skip to content

Study Reveals Belviq Is The First Weight-Loss Medicine With No Heart Risks

A recent research has proved that a medicine has been demonstrated to assist individuals to lose weight and keep it maintained to low for numerous years. Additionally, this drug does not raise their danger of heart problems. This is said to be a very important safety milestone that might cheer broader utilization to assist control the obesity epidemic.

The medicine, Belviq, is present in the U.S. market since 2013.It is said to be early for few latest weight-loss drugs that succeeded in a long-standing heart-safety research. Earlier, the federal regulators mandated the heart safety study of the recent medicine to continue its availability in the market.

Dr. Erin Bohula, the study leader, Brigham & Women’s Hospital in Boston, proclaimed that patients and their physicians have been worried about utilization of these medicines in the treatment of obesity. Bohula added that there is a record of these medicines to have severe complications. The latest Belviq research outcomes were discussed at the European Society of Cardiology in Munich on Sunday. It is also published in the New England Journal of Medicine.

On a similar note, earlier past month, Pernix Therapeutics announced that the firm has purchased the weight-loss drug from Orexigen. Pernix Therapeutics had paid about $73.5 Million for this deal.

In March 2018, Orexigen Therapeutics had filed for bankruptcy. In April 2018, Orexigen entered into an asset acquisition agreement with Nalpropion Pharmaceuticals. According to the deal, Orexigen sold the majority of its assets, depending on the court approval. Nalpropion was created as a special function entity by an investor group, which includes Pernix Therapeutics Holdings.

Now, Pernix is in the process attempting to make Contrave work. The medicine was approved by the U.S. Food and Drug Administration (FDA) in 2014.This drug was the third weight-loss medication that received the FDA since 2012.

Janessa Estrada
STAFF WRITER At ZMR Industry Analysis

Janessa has been working with zmrindustryanalysis.com from last 1 year. She owns Degree of Doctor of Medicine with over 7 years of experience in the medical field. Owing to his friendly nature, she is famous as a social butterfly. Besides her regular work, Janessa keeps herself occupied with several social activities such as organizing free health checkup camps for needy people in rural as well as urban areas.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *